389.80美元1.01(0.26%)
2023/07/28更新
績效 / 1月2.17%
3月7.34%
1年7.16%
晨星評等 - 1.現金0.00%
- 2.股票37.82%
- 3.債券0.00%
- 4.其他62.18%
- 1.美國62.18%
- 2.歐洲不包含歐元區23.16%
- 3.日本5.67%
- 4.英國4.40%
- 5.歐元區2.96%
- 1.健康護理96.57%
- 2.工業2.19%
- 3.基本物料0.73%
- 4.防守性消費0.51%
- 1.UnitedHealth Group Inc8.53%
- 2.Novo Nordisk A/S Class B8.10%
- 3.Roche Holding AG6.89%
- 4.Eli Lilly and Co5.90%
- 5.Vertex Pharmaceuticals Inc5.33%
- 6.Amgen Inc4.95%
- 7.Gilead Sciences Inc4.92%
- 8.Elevance Health Inc4.90%
- 9.GSK PLC4.69%
- 10.Regeneron Pharmaceuticals Inc4.55%
- 1.現金0.00%
- 2.股票37.82%
- 3.債券0.00%
- 4.其他62.18%
- 1.健康護理96.57%
- 2.工業2.19%
- 3.基本物料0.73%
- 4.防守性消費0.51%
- 1.美國62.18%
- 2.歐洲不包含歐元區23.16%
- 3.日本5.67%
- 4.英國4.40%
- 5.歐元區2.96%
- 1.UnitedHealth Group Inc8.53%
- 2.Novo Nordisk A/S Class B8.10%
- 3.Roche Holding AG6.89%
- 4.Eli Lilly and Co5.90%
- 5.Vertex Pharmaceuticals Inc5.33%
- 6.Amgen Inc4.95%
- 7.Gilead Sciences Inc4.92%
- 8.Elevance Health Inc4.90%
- 9.GSK PLC4.69%
- 10.Regeneron Pharmaceuticals Inc4.55%